Emcure Pharmaceuticals posted a 35.4 per cent year-on-year (Y-o-Y) growth in its consolidated net profit at Rs 153.7 crore ...

Solid +5.1% Growth in a Challenging Context Record Results, Reaching 20% Operating Margin Sales: 43.48 billion euros, +5.6% reported and +5.1% like-for-like1. Another year of outperformance in a norma ...

The Conference Forum today announced the launch of the 9th annual Patients as Partners® Europe event, taking place on May 20-21, 2025 at Royal National Hotel in London, UK. The meeting offers an ...

AstraZeneca’s AZN fourth-quarter 2024 core earnings of $1.05 per American depositary share (“ADS”) missed the Zacks Consensus ...

Experts at the 2025 Clinical Trial Supply Europe will explore supply chain challenges and the impact of AI on trials.

BMS acquired Cobenfy as part of its $14 billion takeover of Karuna Therapeutics towards the end of 2023, and analysts at ...

Read on to learn more about the six Australian and New Zealand startups that raised $234.2 million in the legal, healthcare ...

Mallya has moved the high court for data on the total debt recovery made from him by banks. In this article, how the fugitive ...

Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era ...

DelveInsight's Airway Clearance Devices for Cystic Fibrosis Market Insights report provides the current and forecast market ...

Bristol Myers Squibb reported stronger-than-expected earnings for the fourth quarter and full year of 2024, but rising ...